Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial.
Choy MC, Li Wai Suen CFD, Con D, Boyd K, Pena R, Burrell K, Rosella O, Proud D, Brouwer R, Gorelik A, Liew D, Connell WR, Wright EK, Taylor KM, Pudipeddi A, Sawers M, Christensen B, Ng W, Begun J, Radford-Smith G, Garg M, Martin N, van Langenberg DR, Ding NS, Beswick L, Leong RW, Sparrow MP, De Cruz P.
Choy MC, et al. Among authors: leong rw.
Lancet Gastroenterol Hepatol. 2024 Sep 2:S2468-1253(24)00200-0. doi: 10.1016/S2468-1253(24)00200-0. Online ahead of print.
Lancet Gastroenterol Hepatol. 2024.
PMID: 39236736